查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1954250

组织工程市场分析及预测（至2035年）：依类型、产品类型、服务、技术、应用、材料类型、最终用户、製程、模式

Tissue Engineering Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, Material Type, End User, Process, Mode
出版日期: | 出版商: Global Insight Services | 英文 343 Pages | 商品交期: 3-5个工作天内

价格
简介目录

组织工程市场预计将从2024年的139亿美元成长到2034年的471亿美元，复合年增长率约为13.6%。组织工程市场涵盖生物替代物的开发，旨在恢復或改善组织功能。它整合了生物材料、细胞和生化因子，用于再生组织和器官。该市场的成长动力主要来自再生医学的进步、慢性疾病的增加以及器官移植需求的成长。干细胞研究和3D生物列印技术的创新至关重要，它们不仅为市场成长提供了盈利的机会，也有助于解决器官供应严重短缺的问题。

受再生医学进步和器官移植需求不断增长的推动，组织工程市场正经历强劲增长。生物材料领域尤其突出，其中胶原蛋白和透明质酸等天然生物材料因其良好的生物相容性和组织再生功效主导地位。聚合物和陶瓷等合成生物材料凭藉其多功能性和扩充性，成为成长速度第二快的领域。在应用方面，由于骨骼和关节疾病的增加，整形外科和肌肉骨骼系统应用占据主导地位。皮肤和覆盖组织应用紧随其后，反映出人们对有效创伤治疗方案和美容手术的需求日益增长。干细胞技术子领域发展势头强劲，在组织修復和再生方面展现出变革性潜力。研发投入的增加和产学研合作的加强进一步推动了市场成长，为创新治疗方法铺平了道路，并拓展了组织工程解决方案的可能性。

市场区隔
类型 基于支架、基于细胞、3D生物列印、基因治疗
产品 支架、生物反应器、凝胶、微载体
服务 咨询、客製化开发和维护
科技 仿生技术、奈米技术、冷冻保存、生物反应器
应用领域 整形外科、皮肤科、心臟科、神经科、泌尿系统、牙科
材料类型 合成聚合物、天然聚合物、水凝胶、陶瓷
最终用户 医院、研究实验室、生技公司、学术机构
过程 体外、体内、离体
实施例 内部、外包

组织工程市场正经历动态变化，对创新再生医学解决方案日益增长的需求正在影响市场份额。为了因应先进医疗解决方案不断增长的需求，随着企业推出尖端产品，定价策略也在不断演变。新产品频繁发布，体现了该行业致力于创新和满足未被满足的医疗需求。该市场竞争激烈，成功的关键在于敏捷性和适应性。组织工程市场的竞争异常激烈，主要参与者不断相互标桿，以保持竞争优势。监管影响，尤其是在北美和欧洲，在塑造市场动态发挥关键作用。这些法规确保了安全性和有效性，并鼓励企业遵守严格的标准。在干细胞研究、生物材料和3D生物列印技术的进步推动下，该市场呈现成长迹象。儘管监管合规和伦理考量等挑战依然存在，但变革医疗保健的解决方案的潜力蕴藏着盈利的商机。

主要趋势和驱动因素：

受再生医学进步和对器官移植替代方案日益增长的需求推动，组织工程市场正经历强劲增长。关键趋势包括3D生物列印技术的整合，这项技术正在革新复杂组织结构的製造方式。这项创新使得个人化医疗方案能够根据患者的个人需求量身定制，从而改善治疗效果。另一个关键驱动因素是慢性病的增加和人口老化，这推动了对组织工程产品的需求。各国政府和私人企业都在大力投资研发，以加速组织工程应用领域的突破。此外，生物技术公司与学术机构之间的合作正在促进创新，并加速新产品的商业化。生物材料的快速应用也是市场的一大亮点，生物材料在组织再生的支架建造和支持方面发挥关键作用。在医疗基础设施不断完善、再生医学意识日益增强的发展中地区，存在着许多机会。能够提供经济高效且可扩充性解决方案的公司有望占据显着的市场份额。人们越来越重视降低医疗成本和改善病患治疗效果，这进一步推动了组织工程市场的成长。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 鹰架底座
    • 基于细胞
    • 3D生物列印
    • 基因治疗
  • 市场规模及预测：依产品划分
    • 鹰架
    • 生物反应器
    • 凝胶
    • 微载体
  • 市场规模及预测：依服务划分
    • 咨询
    • 客製化开发
    • 维护管理
  • 市场规模及预测：依技术划分
    • 仿生学
    • 奈米科技
    • 冷冻保存
    • 生物反应器
  • 市场规模及预测：依应用领域划分
    • 整形外科
    • 皮肤科
    • 心臟病学
    • 神经病学
    • 泌尿系统
    • 牙科领域
  • 市场规模及预测：依材料类型划分
    • 合成聚合物
    • 天然聚合物
    • 水凝胶
    • 陶瓷
  • 市场规模及预测：依最终用户划分
    • 医院
    • 研究所
    • 生技公司
    • 学术机构
  • 市场规模及预测：依製程划分
    • 体外
    • In vivo
    • Ex Vivo
  • 市场规模及预测：按模式
    • 内部
    • 外包

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • Organogenesis
  • Mi Medx Group
  • Integra Life Sciences
  • Vericel Corporation
  • Athersys
  • Cytori Therapeutics
  • Tissue Regenix Group
  • Coll Plant Biotechnologies
  • Biotime
  • Advanced Cell Technology
  • Regenerys
  • Episkin
  • Histogenics Corporation
  • Medovent
  • Synthecon
  • Biostage
  • Polarity TE
  • Cellular Dynamics International
  • Regenovo Biotechnology
  • Cyfuse Biomedical

第九章：关于我们

简介目录
Product Code: GIS24144

Tissue Engineering Market is anticipated to expand from $13.9 billion in 2024 to $47.1 billion by 2034, growing at a CAGR of approximately 13.6%. The Tissue Engineering Market encompasses the development of biological substitutes to restore or improve tissue function. It integrates biomaterials, cells, and biochemical factors to regenerate tissues and organs. This market is driven by advancements in regenerative medicine, increasing prevalence of chronic diseases, and a growing demand for organ transplantation. Innovations in stem cell research and 3D bioprinting are pivotal, offering lucrative opportunities for growth and addressing critical shortages in organ availability.

The Tissue Engineering Market is experiencing robust growth, propelled by advancements in regenerative medicine and increasing demand for organ transplantation. The biomaterials segment stands out, with natural biomaterials, such as collagen and hyaluronic acid, leading due to their biocompatibility and effectiveness in tissue regeneration. Synthetic biomaterials, including polymers and ceramics, are the second-highest performers, offering versatility and scalability for diverse applications. In the application segment, orthopedics and musculoskeletal hold the top position, driven by the rising incidence of bone and joint disorders. Skin and integumentary applications follow closely, reflecting the growing need for effective wound healing solutions and cosmetic procedures. The stem cell technology sub-segment is gaining momentum, offering transformative potential in tissue repair and regeneration. Increasing investments in research and development and collaborations between academia and industry are further accelerating market growth, paving the way for innovative therapies and expanding the horizon of tissue engineering solutions.

Market Segmentation
TypeScaffold-Based, Cell-Based, 3D Bioprinting, Gene Therapy
ProductScaffolds, Bioreactors, Gels, Microcarriers
ServicesConsulting, Custom Development, Maintenance
TechnologyBiomimetic, Nanotechnology, Cryopreservation, Bioreactors
ApplicationOrthopedics, Dermatology, Cardiology, Neurology, Urology, Dental
Material TypeSynthetic Polymers, Natural Polymers, Hydrogels, Ceramics
End UserHospitals, Research Institutes, Biotechnology Companies, Academic Institutions
ProcessIn Vitro, In Vivo, Ex Vivo
ModeIn-house, Outsourced

The Tissue Engineering Market is witnessing a dynamic shift, with market share being influenced by the increasing demand for innovative regenerative solutions. Pricing strategies are evolving as companies introduce cutting-edge products, catering to the burgeoning need for advanced healthcare solutions. New product launches are frequent, reflecting the industry's commitment to innovation and addressing unmet medical needs. The market is characterized by a competitive landscape where agility and adaptability dictate success. Competition within the Tissue Engineering Market is intense, with key players continuously benchmarking against each other to maintain a competitive edge. Regulatory influences, particularly in North America and Europe, play a critical role in shaping market dynamics. These regulations ensure safety and efficacy, driving companies to adhere to stringent standards. The market is poised for growth, driven by advancements in stem cell research, biomaterials, and 3D bioprinting technologies. Challenges such as regulatory compliance and ethical considerations persist, yet the potential for transformative healthcare solutions offers lucrative opportunities.

Geographical Overview:

The tissue engineering market is witnessing substantial growth across various regions, each exhibiting unique dynamics. North America remains at the forefront, driven by cutting-edge research and substantial funding in regenerative medicine. The presence of leading biotech firms and research institutions further propels market advancements. Europe follows, with a strong emphasis on innovative healthcare solutions and supportive regulatory frameworks fostering growth. The Asia Pacific region is experiencing rapid expansion, fueled by increasing healthcare investments and a burgeoning demand for advanced medical treatments. Emerging economies like China and India are pivotal, with rising healthcare expenditure and technological advancements. Latin America and the Middle East & Africa present burgeoning opportunities. In Latin America, the focus on improving healthcare infrastructure is fostering market growth. Meanwhile, the Middle East & Africa are recognizing the potential of tissue engineering in addressing healthcare challenges, driving investments and innovation in the sector.

The tissue engineering market is navigating complex global tariff structures, geopolitical tensions, and evolving supply chain dynamics. In Japan and South Korea, strategies are pivoting towards enhancing domestic capabilities to mitigate reliance on imports, particularly from politically sensitive regions. China's focus on self-sufficiency is driving substantial investments in local biotechnological advancements. Taiwan, while a hub for innovation, faces geopolitical vulnerabilities that could disrupt supply chains. The global tissue engineering market is experiencing robust growth, driven by technological advancements and increasing healthcare demands. By 2035, the market is expected to flourish, contingent on resilient supply networks and strategic regional collaborations. Middle East conflicts, influencing energy prices, add a layer of unpredictability to manufacturing costs and supply chain stability, necessitating adaptive strategies.

Key Trends and Drivers:

The tissue engineering market is experiencing robust growth, fueled by advancements in regenerative medicine and increasing demand for organ transplantation alternatives. Key trends include the integration of 3D bioprinting technologies, which are revolutionizing the fabrication of complex tissue structures. This innovation is enabling personalized medicine approaches, tailored to individual patient needs, thereby enhancing therapeutic outcomes. Another significant driver is the rising prevalence of chronic diseases and the aging population, which are escalating the demand for tissue-engineered products. Governments and private entities are investing heavily in research and development to accelerate breakthroughs in tissue engineering applications. Furthermore, collaborations between biotechnology firms and academic institutions are fostering innovation and expediting the commercialization of new products. The market is also witnessing a surge in the adoption of biomaterials, which play a crucial role in scaffolding and supporting tissue regeneration. Opportunities abound in developing regions where healthcare infrastructure is expanding, and awareness of regenerative therapies is increasing. Companies that can offer cost-effective and scalable solutions are poised to capture significant market share. The emphasis on reducing healthcare costs and improving patient outcomes is further propelling the growth of the tissue engineering market.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by Material Type
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Scaffold-Based
    • 4.1.2 Cell-Based
    • 4.1.3 3D Bioprinting
    • 4.1.4 Gene Therapy
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Scaffolds
    • 4.2.2 Bioreactors
    • 4.2.3 Gels
    • 4.2.4 Microcarriers
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Consulting
    • 4.3.2 Custom Development
    • 4.3.3 Maintenance
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Biomimetic
    • 4.4.2 Nanotechnology
    • 4.4.3 Cryopreservation
    • 4.4.4 Bioreactors
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Orthopedics
    • 4.5.2 Dermatology
    • 4.5.3 Cardiology
    • 4.5.4 Neurology
    • 4.5.5 Urology
    • 4.5.6 Dental
  • 4.6 Market Size & Forecast by Material Type (2020-2035)
    • 4.6.1 Synthetic Polymers
    • 4.6.2 Natural Polymers
    • 4.6.3 Hydrogels
    • 4.6.4 Ceramics
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Hospitals
    • 4.7.2 Research Institutes
    • 4.7.3 Biotechnology Companies
    • 4.7.4 Academic Institutions
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 In Vitro
    • 4.8.2 In Vivo
    • 4.8.3 Ex Vivo
  • 4.9 Market Size & Forecast by Mode (2020-2035)
    • 4.9.1 In-house
    • 4.9.2 Outsourced

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 Material Type
      • 5.2.1.7 End User
      • 5.2.1.8 Process
      • 5.2.1.9 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 Material Type
      • 5.2.2.7 End User
      • 5.2.2.8 Process
      • 5.2.2.9 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 Material Type
      • 5.2.3.7 End User
      • 5.2.3.8 Process
      • 5.2.3.9 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 Material Type
      • 5.3.1.7 End User
      • 5.3.1.8 Process
      • 5.3.1.9 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 Material Type
      • 5.3.2.7 End User
      • 5.3.2.8 Process
      • 5.3.2.9 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 Material Type
      • 5.3.3.7 End User
      • 5.3.3.8 Process
      • 5.3.3.9 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 Material Type
      • 5.4.1.7 End User
      • 5.4.1.8 Process
      • 5.4.1.9 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 Material Type
      • 5.4.2.7 End User
      • 5.4.2.8 Process
      • 5.4.2.9 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 Material Type
      • 5.4.3.7 End User
      • 5.4.3.8 Process
      • 5.4.3.9 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 Material Type
      • 5.4.4.7 End User
      • 5.4.4.8 Process
      • 5.4.4.9 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 Material Type
      • 5.4.5.7 End User
      • 5.4.5.8 Process
      • 5.4.5.9 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 Material Type
      • 5.4.6.7 End User
      • 5.4.6.8 Process
      • 5.4.6.9 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 Material Type
      • 5.4.7.7 End User
      • 5.4.7.8 Process
      • 5.4.7.9 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 Material Type
      • 5.5.1.7 End User
      • 5.5.1.8 Process
      • 5.5.1.9 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 Material Type
      • 5.5.2.7 End User
      • 5.5.2.8 Process
      • 5.5.2.9 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 Material Type
      • 5.5.3.7 End User
      • 5.5.3.8 Process
      • 5.5.3.9 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 Material Type
      • 5.5.4.7 End User
      • 5.5.4.8 Process
      • 5.5.4.9 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 Material Type
      • 5.5.5.7 End User
      • 5.5.5.8 Process
      • 5.5.5.9 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 Material Type
      • 5.5.6.7 End User
      • 5.5.6.8 Process
      • 5.5.6.9 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 Material Type
      • 5.6.1.7 End User
      • 5.6.1.8 Process
      • 5.6.1.9 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 Material Type
      • 5.6.2.7 End User
      • 5.6.2.8 Process
      • 5.6.2.9 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 Material Type
      • 5.6.3.7 End User
      • 5.6.3.8 Process
      • 5.6.3.9 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 Material Type
      • 5.6.4.7 End User
      • 5.6.4.8 Process
      • 5.6.4.9 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 Material Type
      • 5.6.5.7 End User
      • 5.6.5.8 Process
      • 5.6.5.9 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Organogenesis
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Mi Medx Group
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Integra Life Sciences
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Vericel Corporation
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Athersys
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Cytori Therapeutics
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Tissue Regenix Group
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Coll Plant Biotechnologies
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Biotime
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Advanced Cell Technology
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Regenerys
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Episkin
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Histogenics Corporation
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Medovent
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Synthecon
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Biostage
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Polarity TE
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Cellular Dynamics International
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Regenovo Biotechnology
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Cyfuse Biomedical
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us